329 related articles for article (PubMed ID: 8647932)
1. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
[TBL] [Abstract][Full Text] [Related]
2. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Fruchart JC; Staels B; Auwerx J
J Clin Invest; 1995 Aug; 96(2):741-50. PubMed ID: 7635967
[TBL] [Abstract][Full Text] [Related]
3. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
Staels B; Vu-Dac N; Kosykh VA; Saladin R; Fruchart JC; Dallongeville J; Auwerx J
J Clin Invest; 1995 Feb; 95(2):705-12. PubMed ID: 7860752
[TBL] [Abstract][Full Text] [Related]
4. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
6. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids.
Berthou L; Saladin R; Yaqoob P; Branellec D; Calder P; Fruchart JC; Denèfle P; Auwerx J; Staels B
Eur J Biochem; 1995 Aug; 232(1):179-87. PubMed ID: 7556148
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Staels B; Van Tol A; Fruchart JC; Auwerx J
Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
[TBL] [Abstract][Full Text] [Related]
8. No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased.
Neele DM; Kaptein A; Huisman H; de Wit EC; Princen HM
Biochem Biophys Res Commun; 1998 Mar; 244(2):374-8. PubMed ID: 9514936
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
[TBL] [Abstract][Full Text] [Related]
10. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.
Navarro MA; Carpintero R; Acín S; Arbonés-Mainar JM; Calleja L; Carnicer R; Surra JC; Guzmán-García MA; González-Ramón N; Iturralde M; Lampreave F; Piñeiro A; Osada J
Cytokine; 2005 Jul; 31(1):52-63. PubMed ID: 15878672
[TBL] [Abstract][Full Text] [Related]
11. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
Li H; Gu S; She M
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
[TBL] [Abstract][Full Text] [Related]
12. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism of action of the fibrates].
Fruchart JC; Duriez P; Staels B
J Soc Biol; 1999; 193(1):67-75. PubMed ID: 10851558
[TBL] [Abstract][Full Text] [Related]
14. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
Li H; Gu S; Cao X; Wang Z; She M
Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
16. Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue.
Jové M; Planavila A; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC; Carrera MV
Metabolism; 2003 Mar; 52(3):351-5. PubMed ID: 12647275
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
Zirlik A; Ernst S; Leugers A; Willecke F; Sobel BE; Bode C; Nordt TK
Thromb Haemost; 2009 Jun; 101(6):1060-9. PubMed ID: 19492148
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
Yamazaki K; Kuromitsu J; Tanaka I
Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
